Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
![Foto de Centro de Investigación de Medicina Aplicada (CIMA)](/img/uploaded/775F334D27340F135DFC5AC46D7B50CB.jpg)
![Foto de Institució Catalana de Recerca i Estudis Avançats](/img/noimage_org.png)
Institució Catalana de Recerca i Estudis Avançats
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institució Catalana de Recerca i Estudis Avançats (40)
2024
-
An atlas of cells in the human tonsil
Immunity, Vol. 57, Núm. 2, pp. 379-399.e18
-
Natural Hydrogels Support Kidney Organoid Generation and Promote In Vitro Angiogenesis
Advanced Materials
2023
-
Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study
The Lancet Neurology, Vol. 22, Núm. 12, pp. 1150-1159
-
Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 5000-5014
-
ORC1 binds to cis-transcribed RNAs for efficient activation of replication origins
Nature Communications, Vol. 14, Núm. 1
-
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
Bone Marrow Transplantation
2022
-
A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
Cell Metabolism, Vol. 34, Núm. 6, pp. 857-873.e9
-
Characterization of KRAS-driven NSCLC cell lines with diverse mutational landscape and assessment of their response to MYC inhibition
European Journal of Cancer, Vol. 174, pp. S47
-
Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma
Leukemia, Vol. 36, Núm. 2, pp. 583-587
-
Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts
American Journal of Hematology
2021
-
Cereblon enhancer methylation and IMiD resistance in multiple myeloma
Blood, Vol. 138, Núm. 18, pp. 1721-1726
-
Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma
Leukemia, Vol. 35, Núm. 5, pp. 1438-1450
-
Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
Nature Communications, Vol. 12, Núm. 1
-
Engineering and assessing cardiac tissue complexity
International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-29
-
Gene expression derived from alternative promoters improves prognostic stratification in multiple myeloma
Leukemia, Vol. 35, Núm. 10, pp. 3012-3016
-
Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease
Nature Communications, Vol. 12, Núm. 1
-
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation
Cell Metabolism, Vol. 33, Núm. 2, pp. 379-394.e8
-
The transcription factor SLUG uncouples pancreatic cancer progression from the RAF–MEK1/2–ERK1/2 pathway
Cancer Research, Vol. 81, Núm. 14, pp. 3849-3861
2020
-
2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis
Journal of medicinal chemistry, Vol. 63, Núm. 17, pp. 9237-9257
-
A lncRNA-SWI/SNF complex crosstalk controls transcriptional activation at specific promoter regions
Nature Communications, Vol. 11, Núm. 1